Abstract
Objective: Genetic factors play an important role in thoracic aortic dissection (TAD) etiology and thrombospondin-2 gene (THBS2) polymorphisms may be involved. This study tried to examine the single-nucleotide polymorphisms (SNP) rs8089 of THBS2 for their association with TAD susceptibility in Chinese Han population. Methods: The rs8089 SNP of THBS2 was genotyped in 112 subjects who were diagnosed as TAD and in 184 age- and gender-matched matched controls. Results: The THBS2 rs8089 SNP was associated with increased TAD susceptibility for allele level comparison (P < 0.0001), and for dominant model (P = 0.0073) or extreme genotype model (P = 0.0459) in Chinese Han Population. But for the recessive model, no statistical difference was found (P = 0.099), which may be resulted from the relatively small sample size and low genotype frequency. Conclusion: In conclusion, the present study suggested that the THBS2 rs8089 variant was associated with TAD, with the G allele representing a risk factor in a Chinese Han population.
Keywords: Thrombospondin-2, gene polymorphisms, thoracic aortic dissection
Introduction
Thoracic aortic dissection (TAD), characterized by a tear in the intimal layer of the aorta, aortic aneurysms formation and separation of the arterial wall, is a fatal cardiovascular disease [1]. The thoracic aortic aneurysms tend to be asymptomatic and usually are not noticed before thoracic aortic dissection (TAD) occurs [2]. Nowadays, despite the rapid progress of the current diagnostic and treatment techniques, it is still associated with high morbidity and mortality [3-5], making prevention and early diagnosis critical for survival.
Chronic inflammation, chronic hypertension, dyslipidemia, increased neoangiogenesis, enhanced oxidative stress, and extracellular matrix (ECM) degradation involved in the pathological process of TAD [3,6,7]. However, the cause of TAD has not been clearly proven, with both environmental and genetic factors involved. Previous studies on the genetic basis of TAD were only focused on its relation to systemic connective tissue disorders such as the Marfan syndrome and the Ehlers-Danlos syndrome. However, recent studies showed that up to 19% of individuals with non-syndromic TAD referred for surgery have a familial background, with several genetic loci identified to be associated with nonsyndromatic TAD [8-12]. Nevertheless, the genetic factors that affect susceptibility to this sporadic TAD is still poorly understood though several revealed genetic factors have been found in several populations [13-17].
The thoracic aortic aneurysms and TAD develop as a result of progressive weakening of the aortic wall, including medial degeneration (degeneration and fragmentation of elastic fibers), smooth muscle cells depletion, increased expression and tissue localization of elastin- and collagen-degrading enzymes, and an accumulation of basophilic ground substances [18]. Namely, it means the histological appearance of TAD may be influenced by the balance of vascular smooth muscle cells (VSMCs), ECM proteins proteolytic enzymes, and their inhibitors [19-23].
The thrombospondin-2 gene (THBS2) is a multifunctional protein that plays an autocrine role in the control of smooth muscle cell growth [24]. THBS2 also plays a role in organization of the extracellular matrix, as suggested by the observation that disruption of Thbs2 results in abnormalities of fibroblasts, connective tissue, and blood vessels [25]. Furthermore, a twofold increase in MMP-2 activity was found to contribute to the adhesive defect observed in THBS2-null fibroblasts [26]. Given above, it is interesting if THBS2 may play a role in the pathologies of TAD. A previous study that involved 1351 hypertensive individuals (88 patients with TAD and 1263 controls) demonstrated the THBS2 SNP rs8089 is a risk factor for TAD in hypertensive patients in Japanese population. However, no replicated studies were performed no matter in Japanese or other populations.
Accordingly, the aims of this study were to determine whether the THBS2 SNP rs8089 were associated with TAD in a Chinese Han population.
Methods
The study was approved by the ethics committee of Jining First People’s Hospital, and informed consent was obtained from patients and control participants.
Study population
A total of 112 patients diagnosed with TAD and 184 age- and gender-matched healthy controls were recruited in this study. All subjects included in this study were Chinese Han population. The TAD diagnosis was confirmed by noninvasive imaging such as transesophageal echocardiography, helical computed tomography (CT), or magnetic resonance imaging (MRI) [27]. A complete clinical history was obtained from all subjects. Patients with Marfan syndrome, Ehlers-Danlos syndrome, Loeys-Dietz syndrome, traumatic aneurysms, aortic coarctation, or familial history of TAD were excluded from the study. The clinical examination and radiological assessment were performed by two independent examiners who were blinded to the clinical information. Disagreements were resolved through discussion and consensus. Hypertension was diagnosed as a systolic blood pressure ≥ 140 mmHg, a diastolic blood pressure ≥ 90 mmHg, or treatment with anti-hypertensive medication. Dyslipidemia was defined as total cholesterol > 6.5 mmol/L or treatment for elevated blood lipids. Diabetes was defined as a fasting plasma sugar level > 7.8 mmol/L, a glucose level > 11.1 mmol/L 2 h after oral glucose challenge, or ongoing treatment of diabetes. Clinical data, such as fasting insulin levels and glucose levels, were measured routinely for these individuals.
Genotyping
DNA samples were obtained from all the participants from peripheral blood with the Chelex-100 method [28]. The SNP was then genotyped using Taqman assay (Applied Biosystems 7500, ABI, Foster City, CA) and dual-labeled probes in real-time PCR. The primers and probes were designed and synthesized by Sigma (Sigma-Proligo, The Woodlands, TX). Genotyping was performed by independent laboratory personnel who were blinded to the study, and three authors independently reviewed the genotyping results, data entry, and statistical analyses. In addition, we randomly selected 5% samples of case and control subjects for reproducibility tests at least twice in different days and yielded a 100% concordant.
Statistical analysis
The Statistical Package for Social Sciences software (SPSS, Inc., Chicago, IL, USA), version 16.0 for Windows. The demographic and clinical data were presented as Mean ± SD and compared between groups by the Student’s t-tests. The genotype and allelic frequencies were evaluated by Hardy-Weinberg equilibrium and compared by the Chi-square test. The association between the THBS2 SNP rs8089 polymorphism and TAD susceptibility was assessed under the following genetic models, which were treated as a dichotomous variable: (i) G-allele versus T-allele for allele level comparison; (ii) GT + GG versus TT for a dominant model of the G allele; (iii) GG versus GT + TT for a recessive model of the G-allele; and (iv) GG versus TT for the extreme genotype. P < 0.05 was considered to indicate a statistically significant difference.
Results
Patient characteristics
Demographic data of the population studied and the number of individuals in each group were shown in Table 1. There were no significant differences between groups in terms of the demographic data like age and gender.
Table 1.
Clinical characteristics | AS patients | Controls | P-value |
---|---|---|---|
No. | 112 | 184 | |
Age (years) | 28.3 ± 9.2 | 27.1 ± 6.8 | n.s |
Female/male | 88/24 | 136/48 | n.s |
Smoking | 71 | 84 | n.s |
Diabetes | 23 | 34 | n.s |
Hypertension | 97 | 162 | n.s |
Dyslipidaemia | 68 | 81 | n.s |
Association of THBS2 polymorphism rs8089 with TAD
As expected, the distribution of the genotypes of SNPs of THBS2 rs8089 gene conformed to the Hardy-Weinberg equilibrium and the genotyping success rate was 100%. Table 2 listed the genotyped and allele distributions of the THBS2 rs8089 for the cases and controls. The genotype frequencies of the THBS2 rs8089 T/G polymorphism were 58.0% (TT), 33.9% (GT) and 8.0% (GG) in TAD patients, and 73.4% (TT), 23.4% (GT) and 3.3% (GG) in controls (P = 0.0151). For allele level comparison, the THBS2 rs8089 G allele was associated with an increased risk of TAD in terms of the frequency of allele comparison (G vs. T: OR = 1.90; 95% CI = 1.52 to 2.39, P < 0.0001). For a dominant model of the G allele, the GT + GG genotypes were associated with the risk for TAD (GT + GG vs. TT, OR = 1.99, 95% CI = 1.21 to 3.28, P = 0.0073). For a recessive model of the G allele, the GG homozygote genotype was not associated with susceptibility to TAD (GG vs. GT + TT. OR = 2.59, 95% CI = 0.90 to 7.49, P = 0.099). For the extreme genotype, the GG genotypes were associated with the risk for TAD (GG vs. TT, OR = 3.12, 95% CI = 1.06 to 9.13, P = 0.0459).
Table 2.
Group | Allele (%) | H-WE | |||||||
---|---|---|---|---|---|---|---|---|---|
| |||||||||
TT | GT | GG | GT + GG | GT + TT | GG | T | G | ||
Control | 135 | 43 | 6 | 49 | 178 | 6 | 85.1 | 14.9 | 0.273 |
Case | 65 | 38 | 9 | 47 | 103 | 9 | 75.0 | 25.0 | / |
OR (95% CI) | / | / | 3.12 (1.06 to 9.13) | 1.99 (1.21 to 3.28) | / | 2.59 (0.90 to 7.49) | / | 1.90 (1.52 to 2.39) | / |
P | / | / | 0.0459 | 0.0073 | / | 0.099 | / | < 0.0001 | / |
Discussion
The present study demonstrated that the THBS2 rs8089 SNP was associated with increased TAD susceptibility for allele level comparison, and for dominant model or extreme genotype model in Chinese Han population. But for the recessive model, no statistical difference was found, which may be resulted from the relatively small sample size and low genotype frequency.
Aortic dissection is among the cardiovascular diseases with the highest morbidity and mortality rates. Previous understanding of the pathogenesis of aortic aneurysms focused on the biomechanical factors like hemodynamics and wall mechanics, but recently the genetic risk factors attached more attention [29]. As mentioned in the introduction section, TAD may be introduced by the unbalance of vascular smooth muscle cells (VSMCs), ECM proteins proteolytic enzymes, and their inhibitors (TIMPs). For example, the proteinases of the MMPs family were found able to destruct the elastic media, deteriorate the mechanical properties of the artery wall, and finally contribute to the pathogenesis of TAD [30-33]. And recent studies demonstrated that SMCs participate in remodeling of the aortic wall by production of MMPs and TIMPs in aortic media [31,34]. And the genetic variants may contribute to the amount and function of the VSMCs, MMPs, and TIMPs, thus influence the progression of the TAD formation.
THBS2 belongs to the thrombospondin family, is a disulfide-linked homotrimeric glycoprotein that mediates cell-to-cell and cell-to-matrix interactions. It is a multifunctional protein with autocrine ability to control the growth of SMCs [24]. Increased expression of THBS2 is also found in human hypertrophied hearts, indicating the potential role of THBS2 in SMCs [35]. Moreover, the THBS2 may be also involved in organization of the extracellular matrix, as suggested by the observation that disruption of THBS2 in mice results in a complex phenotype characterized by abnormalities of fibroblasts, connective tissue, and blood vessels that associated with Ehlers-Danlos syndrome type IV [25]. Furthermore, THBS2 is capable of binding both the pro and mature forms of MMP-2, leading to a twofold increase in MMP-2 activity was found to contribute to the adhesive defect observed in THBS2-null fibroblasts [26,35,36].
The most important limitation of the present study is the relatively small sample size. A single center case-control study is not sufficient to fully interpret the relationship between THBS2 polymorphisms and susceptibility to TAD. And as the difference between the groups with the recessive model was not statistically significant, which may be due to the relatively small sample size. Further study with multiple population and larger sample size is needed. Also our investigation is only a genetic association study and the precise impact of this polymorphism on protein function has not been confirmed by molecular biology techniques.
In conclusion, the present study suggested that the THBS2 rs8089 variant was associated with TAD, with the G allele representing a risk factor in Chinese Han population.
Disclosure of conflict of interest
None.
References
- 1.Larson EW, Edwards WD. Risk factors for aortic dissection: a necropsy study of 161 cases. Am J Cardiol. 1984;53:849–855. doi: 10.1016/0002-9149(84)90418-1. [DOI] [PubMed] [Google Scholar]
- 2.Milewicz DM, Guo DC, Tran-Fadulu V, Lafont AL, Papke CL, Inamoto S, Kwartler CS, Pannu H. Genetic basis of thoracic aortic aneurysms and dissections: focus on smooth muscle cell contractile dysfunction. Annu Rev Genomics Hum Genet. 2008;9:283–302. doi: 10.1146/annurev.genom.8.080706.092303. [DOI] [PubMed] [Google Scholar]
- 3.Nienaber CA, Eagle KA. Aortic dissection: new frontiers in diagnosis and management: Part I: from etiology to diagnostic strategies. Circulation. 2003;108:628–635. doi: 10.1161/01.CIR.0000087009.16755.E4. [DOI] [PubMed] [Google Scholar]
- 4.Wang DJ, Fan FD, Wang Q, Li QG, Zhou Q, Wu Z, Shi GF. Preliminary characterization of acute aortic dissection in the mainland of China. Chin Med J (Engl) 2011;124:1726–1730. [PubMed] [Google Scholar]
- 5.Kitai T, Kaji S, Yamamuro A, Tani T, Tamita K, Kinoshita M, Ehara N, Kobori A, Nasu M, Okada Y, Furukawa Y. Clinical outcomes of medical therapy and timely operation in initially diagnosed type a aortic intramural hematoma: a 20-year experience. Circulation. 2009;120:S292–298. doi: 10.1161/CIRCULATIONAHA.108.843615. [DOI] [PubMed] [Google Scholar]
- 6.Trimarchi S, Eagle KA, Nienaber CA, Pyeritz RE, Jonker FH, Suzuki T, O’Gara PT, Hutchinson SJ, Rampoldi V, Grassi V, Bossone E, Muhs BE, Evangelista A, Tsai TT, Froehlich JB, Cooper JV, Montgomery D, Meinhardt G, Myrmel T, Upchurch GR, Sundt TM, Isselbacher EM International Registry of Acute Aortic Dissection (IRAD) Investigator. Importance of refractory pain and hypertension in acute type B aortic dissection: insights from the International Registry of Acute Aortic Dissection (IRAD) Circulation. 2010;122:1283–1289. doi: 10.1161/CIRCULATIONAHA.109.929422. [DOI] [PubMed] [Google Scholar]
- 7.LeMaire SA, Russell L. Epidemiology of thoracic aortic dissection. Nat Rev Cardiol. 2011;8:103–113. doi: 10.1038/nrcardio.2010.187. [DOI] [PubMed] [Google Scholar]
- 8.Pannu H, Fadulu VT, Chang J, Lafont A, Hasham SN, Sparks E, Giampietro PF, Zaleski C, Estrera AL, Safi HJ, Shete S, Willing MC, Raman CS, Milewicz DM. Mutations in transforming growth factor-beta receptor type II cause familial thoracic aortic aneurysms and dissections. Circulation. 2005;112:513–520. doi: 10.1161/CIRCULATIONAHA.105.537340. [DOI] [PubMed] [Google Scholar]
- 9.Zhu L, Vranckx R, Khau Van Kien P, Lalande A, Boisset N, Mathieu F, Wegman M, Glancy L, Gasc JM, Brunotte F, Bruneval P, Wolf JE, Michel JB, Jeunemaitre X. Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. Nat Genet. 2006;38:343–349. doi: 10.1038/ng1721. [DOI] [PubMed] [Google Scholar]
- 10.Guo DC, Pannu H, Tran-Fadulu V, Papke CL, Yu RK, Avidan N, Bourgeois S, Estrera AL, Safi HJ, Sparks E, Amor D, Ades L, McConnell V, Willoughby CE, Abuelo D, Willing M, Lewis RA, Kim DH, Scherer S, Tung PP, Ahn C, Buja LM, Raman CS, Shete SS, Milewicz DM. Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat Genet. 2007;39:1488–1493. doi: 10.1038/ng.2007.6. [DOI] [PubMed] [Google Scholar]
- 11.Regalado ES, Guo DC, Villamizar C, Avidan N, Gilchrist D, McGillivray B, Clarke L, Bernier F, Santos-Cortez RL, Leal SM, Bertoli-Avella AM, Shendure J, Rieder MJ, Nickerson DA NHLBI GO Exome Sequencing Project. Milewicz DM. Exome sequencing identifies SMAD3 mutations as a cause of familial thoracic aortic aneurysm and dissection with intracranial and other arterial aneurysms. Circ Res. 2011;109:680–686. doi: 10.1161/CIRCRESAHA.111.248161. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Wang L, Guo DC, Cao J, Gong L, Kamm KE, Regalado E, Li L, Shete S, He WQ, Zhu MS, Offermanns S, Gilchrist D, Elefteriades J, Stull JT, Milewicz DM. Mutations in myosin light chain kinase cause familial aortic dissections. Am J Hum Genet. 2010;87:701–707. doi: 10.1016/j.ajhg.2010.10.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Wang Y, Zhang W, Zhang Y, Yang Y, Sun L, Hu S, Chen J, Zhang C, Zheng Y, Zhen Y, Sun K, Fu C, Yang T, Wang J, Sun J, Wu H, Glasgow WC, Hui R. VKORC1 haplotypes are associated with arterial vascular diseases (stroke, coronary heart disease, and aortic dissection) Circulation. 2006;113:1615–1621. doi: 10.1161/CIRCULATIONAHA.105.580167. [DOI] [PubMed] [Google Scholar]
- 14.Chen L, Wang X, Carter SA, Shen YH, Bartsch HR, Thompson RW, Coselli JS, Wilcken DL, Wang XL, LeMaire SA. A single nucleotide polymorphism in the matrix metalloproteinase 9 gene (-8202A/G) is associated with thoracic aortic aneurysms and thoracic aortic dissection. J Thorac Cardiovasc Surg. 2006;131:1045–1052. doi: 10.1016/j.jtcvs.2006.01.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Tangurek B, Ketenci B, Ozay B, Ozer N, Yilmaz H, Sayar N, Ciloglu F, Gorur A, Bolca O. Lack of association between angiotensin-converting enzyme gene polymorphism and type I aortic dissection. J Int Med Res. 2008;36:714–720. doi: 10.1177/147323000803600413. [DOI] [PubMed] [Google Scholar]
- 16.Kalay N, Caglayan O, Akkaya H, Ozdogru I, Dogan A, Inanc MT, Kaya MG, Ergin A, Topsakal R, Ciçek D, Eryol NK, Tasdemir K, Oguzhan A, Dundar M. The deletion polymorphism of the angiotensin-converting enzyme gene is associated with acute aortic dissection. Tohoku J Exp Med. 2009;219:33–37. doi: 10.1620/tjem.219.33. [DOI] [PubMed] [Google Scholar]
- 17.Liu O, Li JR, Gong M, Xu M, Du J, Zhang HJ. Genetic analysis of six SNPs in candidate genes associated with high cross-race risk of development of thoracic aortic aneurysms and dissections in Chinese Han population. Acta Pharmacol Sin. 2010;31:1376–1380. doi: 10.1038/aps.2010.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Barbour JR, Spinale FG, Ikonomidis JS. Proteinase systems and thoracic aortic aneurysm progression. J Surg Res. 2007;139:292–307. doi: 10.1016/j.jss.2006.09.020. [DOI] [PubMed] [Google Scholar]
- 19.Manabe T, Imoto K, Uchida K, Doi C, Takanashi Y. Decreased tissue inhibitor of metalloproteinase-2/matrix metalloproteinase ratio in the acute phase of aortic dissection. Surg Today. 2004;34:220–225. doi: 10.1007/s00595-003-2683-3. [DOI] [PubMed] [Google Scholar]
- 20.Akiyama M, Ohtani H, Sato E, Nagura H, Tabayashi K. Up-regulation of matrix metalloproteinase-2 and membrane-type 1-matrix metalloproteinase were coupled with that of type I procollagen in granulation tissue response after the onset of aortic dissection. Virchows Arch. 2006;448:811–821. doi: 10.1007/s00428-006-0194-5. [DOI] [PubMed] [Google Scholar]
- 21.Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol. 2007;8:221–233. doi: 10.1038/nrm2125. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Raffetto JD, Khalil RA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol. 2008;75:346–359. doi: 10.1016/j.bcp.2007.07.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003;92:827–839. doi: 10.1161/01.RES.0000070112.80711.3D. [DOI] [PubMed] [Google Scholar]
- 24.Majack RA, Goodman LV, Dixit VM. Cell surface thrombospondin is functionally essential for vascular smooth muscle cell proliferation. J Cell Biol. 1988;106:415–422. doi: 10.1083/jcb.106.2.415. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Kyriakides TR, Zhu YH, Smith LT, Bain SD, Yang Z, Lin MT, Danielson KG, Iozzo RV, LaMarca M, McKinney CE, Ginns EI, Bornstein P. Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J Cell Biol. 1998;140:419–430. doi: 10.1083/jcb.140.2.419. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Yang Z, Kyriakides TR, Bornstein P. Matricellular proteins as modulators of cell-matrix interactions: adhesive defect in thrombospondin 2-null fibroblasts is a consequence of increased levels of matrix metalloproteinase-2. Mol Biol Cell. 2000;11:3353–3364. doi: 10.1091/mbc.11.10.3353. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Isselbacher EM. Thoracic and abdominal aortic aneurysms. Circulation. 2005;111:816–828. doi: 10.1161/01.CIR.0000154569.08857.7A. [DOI] [PubMed] [Google Scholar]
- 28.Walsh PS, Metzger DA, Higuchi R. Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques. 1991;10:506–513. [PubMed] [Google Scholar]
- 29.Thompson RW. Reflections on the pathogenesis of abdominal aortic aneurysms. Cardiovasc Surg. 2002;10:389–394. doi: 10.1016/s0967-2109(02)00042-x. [DOI] [PubMed] [Google Scholar]
- 30.Chung AW, Au Yeung K, Sandor GG, Judge DP, Dietz HC, van Breemen C. Loss of elastic fiber integrity and reduction of vascular smooth muscle contraction resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in the thoracic aortic aneurysm in Marfan syndrome. Circ Res. 2007;101:512–522. doi: 10.1161/CIRCRESAHA.107.157776. [DOI] [PubMed] [Google Scholar]
- 31.Kamijima T, Isobe M, Suzuki J, Fukui D, Arai M, Urayama H, Nishimaki K, Sekiguchi M, Kawasaki S. Enhanced embryonic nonmuscle myosin heavy chain isoform and matrix metalloproteinase expression in aortic abdominal aneurysm with rapid progression. Cardiovasc Pathol. 1999;8:291–295. doi: 10.1016/s1054-8807(99)00014-9. [DOI] [PubMed] [Google Scholar]
- 32.Taketani T, Imai Y, Morota T, Maemura K, Morita H, Hayashi D, Yamazaki T, Nagai R, Takamoto S. Altered patterns of gene expression specific to thoracic aortic aneurysms: microarray analysis of surgically resected specimens. Int Heart J. 2005;46:265–277. doi: 10.1536/ihj.46.265. [DOI] [PubMed] [Google Scholar]
- 33.Absi TS, Sundt TM 3rd, Tung WS, Moon M, Lee JK, Damiano RR Jr, Thompson RW. Altered patterns of gene expression distinguishing ascending aortic aneurysms from abdominal aortic aneurysms: complementary DNA expression profiling in the molecular characterization of aortic disease. J Thorac Cardiovasc Surg. 2003;126:344–357. doi: 10.1016/s0022-5223(02)73576-9. discission 357. [DOI] [PubMed] [Google Scholar]
- 34.Lesauskaite V, Tanganelli P, Sassi C, Neri E, Diciolla F, Ivanoviene L, Epistolato MC, Lalinga AV, Alessandrini C, Spina D. Smooth muscle cells of the media in the dilatative pathology of ascending thoracic aorta: morphology, immunoreactivity for osteopontin, matrix metalloproteinases, and their inhibitors. Hum Pathol. 2001;32:1003–1011. doi: 10.1053/hupa.2001.27107. [DOI] [PubMed] [Google Scholar]
- 35.Schroen B, Heymans S, Sharma U, Blankesteijn WM, Pokharel S, Cleutjens JP, Porter JG, Evelo CT, Duisters R, van Leeuwen RE, Janssen BJ, Debets JJ, Smits JF, Daemen MJ, Crijns HJ, Bornstein P, Pinto YM. Thrombospondin-2 is essential for myocardial matrix integrity: increased expression identifies failure-prone cardiac hypertrophy. Circ Res. 2004;95:515–522. doi: 10.1161/01.RES.0000141019.20332.3e. [DOI] [PubMed] [Google Scholar]
- 36.Yang Z, Strickland DK, Bornstein P. Extracellular matrix metalloproteinase 2 levels are regulated by the low density lipoprotein-related scavenger receptor and thrombospondin 2. J Biol Chem. 2001;276:8403–8408. doi: 10.1074/jbc.M008925200. [DOI] [PubMed] [Google Scholar]